StockNews.com started coverage on shares of VolitionRx (NYSE:VNRX – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “sell” rating on the stock. VNRX has been the ...
Learn more about whether Biogen Inc. or Natera, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.